Vaksin Covid-19 Pfizer–BioNTech (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaksin Covid-19 Pfizer–BioNTech" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

4bbc.com

20^th place

50^th place

2nih.gov

4^th place

13^th place

2doi.org

2^nd place

4^th place

2statnews.com

8,771^st place

low place

2nytimes.com

7^th place

35^th place

2fda.gov

447^th place

792^nd place

1clinicaltrials.gov

5,225^th place

low place

1npr.org

92^nd place

444^th place

1cnbc.com

220^th place

474^th place

1nbcnews.com

137^th place

852^nd place

1bloomberg.com

99^th place

159^th place

1fortune.com

433^rd place

374^th place

1jakartaglobe.id

low place

340^th place

1globalnews.ca

985^th place

6,809^th place

1gov.uk

432^nd place

1,425^th place

1apnews.com

129^th place

478^th place

19news.com.au

4,754^th place

low place

1aljazeera.com

268^th place

301^st place

9news.com.au

"Bahrain becomes second nation to grant emergency use for Pfizer, BioNTech vaccine" (dalam bahasa Inggris). 5 December 2020. Diakses tanggal 5 December 2020.

aljazeera.com

"Bahrain becomes second country to approve Pfizer COVID-19 vaccine". Al Jazeera. 2020-12-04.

apnews.com

Neergaard L, Kirka D (2020-12-02). "Britain OKs Pfizer vaccine and will begin shots within days". AP.

bbc.com

Gallagher J (9 November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Diakses tanggal 9 November 2020.
Gallagher J (9 November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Diakses tanggal 9 November 2020.
Gallagher J (9 November 2020). "Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. Diakses tanggal 9 November 2020.
Roberts M (2 December 2020). "Covid Pfizer vaccine approved for use next week in UK". BBC (dalam bahasa Inggris). Diakses tanggal 2 December 2020.

bloomberg.com

"Deep-freeze hurdle makes Pfizer's vaccine one for the rich". Bloomberg. 10 November 2020. Diakses tanggal 12 November 2020. Vaccine goes bad five days after thawing, requires two shots; Many nations face costly ramp up of cold-chain infrastructure

clinicaltrials.gov

Nomor uji klinis NCT04368728 for "NCT04368728: Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals" di ClinicalTrials.gov

cnbc.com

Meredith S (9 November 2020). "Pfizer, BioNTech say Covid vaccine is more than 90% effective—'great day for science and humanity'". CNBC.

doi.org

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (October 2020). "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates". The New England Journal of Medicine: NEJMoa2027906. doi:10.1056/NEJMoa2027906. PMC 7583697 . PMID 33053279 Periksa nilai |pmid= (bantuan).
Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (August 2020). "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study". medRxiv: 2020.08.17.20176651. doi:10.1101/2020.08.17.20176651. PMID 32839784.

fda.gov

"Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate". U.S. Food and Drug Administration (FDA) (Siaran pers). Diakses tanggal 20 November 2020. Artikel ini memuat teks dari sumber tersebut, yang berada dalam ranah publik.
"Emergency Use Authorization for vaccines explained". U.S. Food and Drug Administration. 20 November 2020. Diakses tanggal 20 November 2020. Artikel ini memuat teks dari sumber tersebut, yang berada dalam ranah publik.

fortune.com

"How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca". Fortune. 5 December 2020.

globalnews.ca

Dangerfield K (2020-11-20). "Pfizer files for emergency use of coronavirus vaccine in U.S. — what about in Canada?". Global News. Diakses tanggal 2020-11-25.

gov.uk

"UK medicines regulator gives approval for first UK COVID-19 vaccine". GOV.UK (dalam bahasa Inggris). 2 December 2020. Diakses tanggal 2 December 2020.

jakartaglobe.id

"Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss". Jakarta Globe. 22 November 2020.

nbcnews.com

Edwards E (9 November 2020). "Pfizer's Covid-19 vaccine promising, but many questions remain". NBC News. Diakses tanggal 12 November 2020.

nih.gov

ncbi.nlm.nih.gov

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (October 2020). "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates". The New England Journal of Medicine: NEJMoa2027906. doi:10.1056/NEJMoa2027906. PMC 7583697 . PMID 33053279 Periksa nilai |pmid= (bantuan).
Walsh EE, Frenck R, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. (August 2020). "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study". medRxiv: 2020.08.17.20176651. doi:10.1101/2020.08.17.20176651. PMID 32839784.

npr.org

Palca J (9 November 2020). "Pfizer says experimental COVID-19 vaccine is more than 90% effective". NPR.

nytimes.com

Zimmer C (20 November 2020). "2 Companies Say Their Vaccines Are 95% Effective. What Does That Mean? You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that's not how the math works". The New York Times. Diakses tanggal 21 November 2020.
Mueller B (2020-12-02). "U.K. Approves Pfizer Coronavirus Vaccine, a First in the West". The New York Times. Diakses tanggal 2020-12-02.

statnews.com

Herper M (9 November 2020). "Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate". STAT. Diakses tanggal 9 November 2020.
Branswell H (20 November 2020). "Pfizer, BioNTech submit formal application to FDA to authorize Covid-19 vaccine". STAT. Diakses tanggal 25 November 2020.